A Phase 2 Study of TRK-130 in Patients With Overactive Bladder
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Naltalimide (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Toray Industries
- 06 Jun 2016 New trial record